Revaccination recommendations should be designed to create and maintain immunity to disease while minimizing the risk of adverse effects. The practice of revaccinating animals annually is largely based on historic precedent supported by minimal scientific data. There is increasing evidence that some vaccines provide immunity beyond 1 year. Unnecessary stimulation of the immune system does not result in increased resistance to disease and may expose animals to unnecessary risks.
Vaccines should be divided into two classes: core and noncore. Core vaccines are defined as those that are appropriate to provide protection in most animals against diseases that pose a risk of severe disease because the pathogens are virulent, highly infectious, and widely distributed in the region. Core vaccines are considered to be highly efficacious, to have benefit-risk ratios high enough to warrant their general use, to be of substantial public health importance, or are required by law. Noncore vaccines meet one or more of the following conditions: they target diseases that are of limited risk in the geographic region or in the lifestyle of the pet, they help protect against diseases that represent less severe threats to infected animals, their benefit-risk ratios are too low to warrant product use in all circumstances, or inadequate scientific information is available to evaluate them. Veterinarians and owners/clients need to carefully consider the benefits and risks of using noncore vaccine products on an individual basis.
The Council has identified those vaccines which are core and noncore for both dogs and cats, and they are listed in the following tables: 
